Cephalon, Inc.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Cephalon, Inc..The latest application filed is for "antibodies that specifically bind to tl1a".
Company Profile
27.200.200
Trademarks
- Cephalon, Inc. - Frazer PA US
- Cephalon, Inc. - West Chester PA US
- Cephalon, Inc. - North Wales PA US
- CEPHALON, INC. - Parsippany NJ US
- Cephalon, Inc. - Wilmingotn DE
- Cephalon, Inc - Frazer PA
- Cephalon, Inc. - Frazier PA
- Cephalon, Inc. - Wilmington DE
- Cephalon, Inc. - 145 Brandywine Parkway West Chester PA
- Cephalon, Inc. - 41 Moores Road PO Box 4011 Frazer PA
- Cephalon, Inc. - Fzazer PA
- Cephalon, Inc. - 41 Moores Road Frazer PA
- Cephalon Inc - West Chester PA
Trademarks
Patent Activity
| Patent | Date |
|---|---|
| Cation exchange chromatography wash buffer Grant 11,426,706 - Wang , et al. August 30, 2 | 2022-08-30 |
| Antibodies That Specifically Bind To TL1A App 20220185902 - POULTON; Lynn Dorothy ; et al. | 2022-06-16 |
| Anti-CXCR2 antibodies and uses thereof Grant 11,332,534 - Shim Siew Chen , et al. May 17, 2 | 2022-05-17 |
| Antibodies That Specifically Bind To Human Il-15 And Uses Thereof App 20220127352 - LAINE; David Jose Simon ; et al. | 2022-04-28 |
| Antibodies that specifically bind to human IL-15 and uses thereof Grant 11,267,883 - Laine , et al. March 8, 2 | 2022-03-08 |
| Anti-par-2 Antibodies And Methods Of Use Thereof App 20220056125 - BRACKEN; Anna Mikaela ; et al. | 2022-02-24 |
| Treatment strategy for non-responders to 100MG subcutaneous mepolizumab Grant 11,224,653 - Nair , et al. January 18, 2 | 2022-01-18 |
| Antibodies that specifically bind to TL1A and methods of treating respiratory tract diseases Grant 11,220,549 - Poulton , et al. January 11, 2 | 2022-01-11 |
| Pharmaceutical Prodrugs And Methods Of Their Preparation And Use App 20210361777 - DRAGER; Anthony S. ; et al. | 2021-11-25 |
| Anti-IL-5 Antibodies App 20210355205 - Liddament; Mark Terence ; et al. | 2021-11-18 |
| Anti-IL-5 antibodies Grant 11,111,292 - Liddament , et al. September 7, 2 | 2021-09-07 |
| Pharmaceutical prodrugs and methods of their preparation and use Grant 11,071,789 - Drager , et al. July 27, 2 | 2021-07-27 |
| Liquid Formulations Of Bendamustine App 20210113530 - Drager; Anthony S. ; et al. | 2021-04-22 |
| Antibody variants transmigrating the blood-brain barrier and uses thereof Grant 10,906,973 - Stanimirovic , et al. February 2, 2 | 2021-02-02 |
| Liquid Formulations Of Bendamustine App 20210008035 - Drager; Anthony S. ; et al. | 2021-01-14 |
| Novel Solid Forms Of Bendamustine Hydrochloride App 20200323824 - Cooper; Martin Ian ; et al. | 2020-10-15 |
| Antibodies That Specifically Bind To Human Il-15 And Uses Thereof App 20200270339 - LAINE; David Jose Simon ; et al. | 2020-08-27 |
| Bendamustine Pharmaceutical Compositions App 20200237726 - Brittain; Jason Edward ; et al. | 2020-07-30 |
| Affinity chromatography wash buffer Grant 10,688,412 - Wang , et al. | 2020-06-23 |
| Fused bicyclic 2,4-diaminopyrimidine derivative as a dual ALK and FAK inhibitor Grant 10,632,119 - Allwein , et al. | 2020-04-28 |
| Antibody Variants Transmigrating The Blood-brain Barrier And Uses Thereof App 20200095316A1 - | 2020-03-26 |
| Use of reslizumab to treat moderate to severe eosinophilic asthma Grant 10,577,414 - O'Brien , et al. | 2020-03-03 |
| Anti-cxcr2 Antibodies And Uses Thereof App 20200040089 - Shim Siew Chen; Doris ; et al. | 2020-02-06 |
| Substituted 4-benzyl And 4-benzoyl Piperidine Derivatives App 20200031797 - BECKNELL; Nadine C. ; et al. | 2020-01-30 |
| Solid forms of bendamustine hydrochloride Grant 10,517,852 - Cooper , et al. Dec | 2019-12-31 |
| Fused Bicyclic 2,4-Diaminopyrimidine Derivative as a Dual ALK and FAK Inhibitor App 20190328735 - Allwein; Shawn P. ; et al. | 2019-10-31 |
| Prodrugs of Chlorokynurenines App 20190308934 - Laufer; Ralph ; et al. | 2019-10-10 |
| Pharmaceutical Prodrugs And Methods Of Their Preparation And Use App 20190240348 - DRAGER; Anthony S. ; et al. | 2019-08-08 |
| Methods for preparing fused bicyclic 2, 4-diaminopyrimidine derivatives Grant 10,259,794 - Allwein , et al. | 2019-04-16 |
| Antibodies That Specifically Bind To TL1A App 20190106486 - Poulton; Lynn Dorothy ; et al. | 2019-04-11 |
| Treatment Strategy For Non-responders To 100mg Subcutaneous Mepolizumab App 20190062421 - Nair; Parameswaran ; et al. | 2019-02-28 |
| Cation Exchange Chromatography Wash Buffer App 20190046956 - WANG; Lu ; et al. | 2019-02-14 |
| Nanoparticulate and macroparticulate formulations Grant 10,201,506 - Brown , et al. Feb | 2019-02-12 |
| Novel Solid Forms Of Bendamustine Hydrochloride App 20190015390 - Cooper; Martin Ian ; et al. | 2019-01-17 |
| Crystalline forms of PARP inhibitors Grant 10,150,772 - Bierlmaier , et al. Dec | 2018-12-11 |
| Antibodies that specifically bind to TL1A Grant 10,138,296 - Poulton , et al. Nov | 2018-11-27 |
| Prodrugs Of Chlorokynurenines App 20180327351 - LAUFER; Ralph ; et al. | 2018-11-15 |
| Fused bicyclic 2,4-diaminopyrimidine derivative as a dual ALK and FAK inhibitor Grant 10,111,872 - Allwein , et al. October 30, 2 | 2018-10-30 |
| Bendamustine Pharmaceutical Compositions App 20180296534 - Brittain; Jason Edward ; et al. | 2018-10-18 |
| Solid forms of bendamustine hydrochloride Grant 10,039,750 - Cooper , et al. August 7, 2 | 2018-08-07 |
| Anti-IL-5 Antibodies App 20180186873 - Liddament; Mark Terence ; et al. | 2018-07-05 |
| 1,4-substituted Piperidine Derivatives App 20180179159 - Becknell; Nadine C. ; et al. | 2018-06-28 |
| Inhalation Systems, Devices and Methods App 20180056018 - Canvin; Janice M.G. ; et al. | 2018-03-01 |
| 1,4-substituted piperidine derivatives Grant 9,902,696 - Becknell , et al. February 27, 2 | 2018-02-27 |
| Use of Reslizumab to Treat Moderate to Severe Eosinophilic Asthma App 20180030131 - Obrien; Christopher ; et al. | 2018-02-01 |
| Affinity Chromatography Wash Buffer App 20180021696 - WANG; Lu ; et al. | 2018-01-25 |
| Methods For Preparing Fused Bicyclic 2, 4-diaminopyrimidine Derivatives App 20170369451 - ALLWEIN; Shawn P. ; et al. | 2017-12-28 |
| Use of reslizumab to treat moderate to severe eosinophilic asthma Grant 9,815,894 - O'Brien , et al. November 14, 2 | 2017-11-14 |
| Crystalline Forms Of Parp Inhibitors App 20170267683 - BIERLMAIER; Stephen J. ; et al. | 2017-09-21 |
| Fused Bicyclic 2,4-diaminopyrimidine Derivative As A Dual Alk And Fak Inhibitor App 20170173017 - Allwein; Shawn P. ; et al. | 2017-06-22 |
| Nanoparticulate And Macroparticulate Formulations App 20170143640 - Brown; Peter D. ; et al. | 2017-05-25 |
| Fused bicyclic 2,4-diaminopyrimidine derivative as a dual ALK and FAK inhibitor Grant 9,623,026 - Allwein , et al. April 18, 2 | 2017-04-18 |
| Antibodies That Specifically Bind To Tl1a App 20170081400 - Poulton; Lynn Dorothy ; et al. | 2017-03-23 |
| Nanoparticulate and macroparticulate formulations Grant 9,598,377 - Brown , et al. March 21, 2 | 2017-03-21 |
| Novel Solid Forms Of Bendamustine Hydrochloride App 20170071913 - Cooper; Martin Ian ; et al. | 2017-03-16 |
| Macrocyclic Compounds As Alk, Fak And Jak2 Inhibitors App 20170027948 - Breslin; Henry J. ; et al. | 2017-02-02 |
| Substituted Aromatic Sulfur Compounds and Methods of Their Use App 20170029367 - Dorsey; Bruce D. ; et al. | 2017-02-02 |
| Solid forms of bendamustine hydrochloride Grant 9,533,955 - Cooper , et al. January 3, 2 | 2017-01-03 |
| 1,4-substituted Piperidine Derivatives App 20160368874 - Becknell; Nadine C. ; et al. | 2016-12-22 |
| Pyrrolotriazines As Alk Inhibitors App 20160347756 - Haltiwanger; Ralph C. ; et al. | 2016-12-01 |
| Macrocyclic compounds as ALK, FAK and JAK2 inhibitors Grant 9,487,529 - Breslin , et al. November 8, 2 | 2016-11-08 |
| Pyrazolo[1,5-a]pyridine Derivatives And Methods Of Their Use App 20160318929 - Hudkins; Robert L ; et al. | 2016-11-03 |
| Substituted aromatic sulfur compounds and methods of their use Grant 9,475,766 - Dorsey , et al. October 25, 2 | 2016-10-25 |
| Treatment Of Multiple Sclerosis With A 1,2,4-triazolo [1,5a] Pyridine Derivative App 20160303116 - DOBRZANSKI; Pawel T. ; et al. | 2016-10-20 |
| Pyrrolotriazines as ALK inhibitors Grant 9,440,984 - Haltiwanger , et al. September 13, 2 | 2016-09-13 |
| Fused Bicyclic 2,4-diaminopyrimidine Derivative As A Dual Alk And Fak Inhibitor App 20160243119 - Allwein; Shawn P. ; et al. | 2016-08-25 |
| Novel Solid Forms Of Bendamustine Hydrochloride App 20160159748 - Cooper; Martin Ian ; et al. | 2016-06-09 |
| Fused bicyclic 2,4-diaminopyrimidine derivative as a dual ALK and FAK inhibitor Grant 9,339,502 - Allwein , et al. May 17, 2 | 2016-05-17 |
| Proteasome inhibitor delanzomib for use in the treatment of lupus Grant 9,340,559 - Ruggeri , et al. May 17, 2 | 2016-05-17 |
| Pyrrolotriazines As Alk Inhibitors App 20160068535 - Haltiwanger; Ralph C. ; et al. | 2016-03-10 |
| Imidazo[4,5-b]pyridine derivatives as ALK and JAK modulators for the treatment of proliferative disorders Grant 9,238,656 - Breslin , et al. January 19, 2 | 2016-01-19 |
| Proteasome inhibitors and methods of using the same Grant 9,233,115 - Bernardini , et al. January 12, 2 | 2016-01-12 |
| Nanoparticulate And Macroparticulate Formulations App 20160002173 - BROWN; Peter D. ; et al. | 2016-01-07 |
| Child Resistant Cover for Oral Dosage Forms App 20160001957 - Bradway; Randy J. ; et al. | 2016-01-07 |
| Bendamustine Pharmaceutical Compositions App 20150374671 - Brittain; Jason Edward ; et al. | 2015-12-31 |
| Fused Bicyclic 2,4-diaminopyrimidine Derivative as a Dual ALK and FAK Inhibitor App 20150374693 - Allwein; Shawn P. ; et al. | 2015-12-31 |
| Tricyclic Derivatives and Their Pharmaceutical Use and Compositions App 20150368257 - Allwein; Shawn P. ; et al. | 2015-12-24 |
| Liquid Formulations of Bendamustine App 20150335750 - Drager; Anthony S. ; et al. | 2015-11-26 |
| Fused bicyclic 2,4-diaminopyrimidine derivative as a dual ALK and FAK inhibitor Grant 9,132,128 - Allwein , et al. September 15, 2 | 2015-09-15 |
| Tricyclic derivatives and their pharmaceutical use and compositions Grant 9,115,147 - Allwein , et al. August 25, 2 | 2015-08-25 |
| Treatment of chronic inflammation with a 1,2,4-triazolo [1,5a] pyridine derivative Grant 9,034,876 - Dobrzanski , et al. May 19, 2 | 2015-05-19 |
| Janus kinase 2 (JAK2) inhibitor for the treatment of lupus Grant 9,023,853 - Dobrzanski , et al. May 5, 2 | 2015-05-05 |
| Novel Solid Forms Of Bendamustine Hydrochloride App 20150051258 - Cooper; Martin Ian ; et al. | 2015-02-19 |
| Processes For Preparing (r)-2-methylpyrrolidine And (s)-2-methylpyrrolidine And Tartrate Salts Thereof App 20150011759 - Christie; Michael ; et al. | 2015-01-08 |
| Fused Bicyclic 2,4-diaminopyrimidine Derivative as a Dual ALK and FAK Inhibitor App 20150011561 - Allwein; Shawn P. ; et al. | 2015-01-08 |
| Substituted pyridazine derivatives Grant 8,912,183 - Hudkins , et al. December 16, 2 | 2014-12-16 |
| Imidazo[4,5-b]pyridine Derivatives as ALK and JAK Modulators for the Treatment of Proliferative Disorders App 20140350011 - Breslin; Henry J. ; et al. | 2014-11-27 |
| Bendamustine pharmaceutical compositions Grant 8,895,756 - Brittain , et al. November 25, 2 | 2014-11-25 |
| Method for purifying a fused pyrrolocarbazole derivative Grant 8,884,014 - Allwein , et al. November 11, 2 | 2014-11-11 |
| Solid forms of bendamustine hydrochloride Grant 8,883,836 - Cooper , et al. November 11, 2 | 2014-11-11 |
| Thienopyrimidine Inhibitors of Atypical Protein Kinase C App 20140323435 - Dorsey; Bruce D. ; et al. | 2014-10-30 |
| Pharmaceutical formulations of modafinil Grant 8,859,621 - Heacock , et al. October 14, 2 | 2014-10-14 |
| Substituted Phenoxypropylcycloamine Derivatives As Histamine-3 (h3) Receptor Ligands App 20140296212 - Bacon; Edward R. ; et al. | 2014-10-02 |
| Solid State Forms of 6-[4-[3-((R)-2-Methylpyrrolidine-1-yl)-propoxy]phenyl] 2H-pyridazine-3-one Hydrochloride App 20140275102 - Bierlmaier; Stephen J. ; et al. | 2014-09-18 |
| Uracil Derivatives As Axl And C-met Kinase Inhibitors App 20140275077 - Dandu; Reddeppa Reddy ; et al. | 2014-09-18 |
| Modafinil compositions Grant 8,809,586 - Hickey , et al. August 19, 2 | 2014-08-19 |
| Sublingual buccal effervescent Grant 8,802,130 - Pather , et al. August 12, 2 | 2014-08-12 |
| Bendamustine pharmaceutical compositions Grant 8,791,270 - Brittain , et al. July 29, 2 | 2014-07-29 |
| Liquid Formulations Of Bendamustine App 20140206733 - Drager; Anthony S. ; et al. | 2014-07-24 |
| Lyophilization cakes of proteasome inhibitors Grant 8,785,418 - Bricout , et al. July 22, 2 | 2014-07-22 |
| Novel Solid Forms Of Bendamustine Hydrochloride App 20140187598 - Cooper; Martin Ian ; et al. | 2014-07-03 |
| Combination therapy for the treatment of multiple myeloma Grant 8,765,720 - Berenson July 1, 2 | 2014-07-01 |
| Transmucosal effervescent Grant 8,765,100 - Eichman , et al. July 1, 2 | 2014-07-01 |
| Tricyclic derivatives and their pharmaceutical use and compositions Grant 8,765,779 - Bacon , et al. July 1, 2 | 2014-07-01 |
| Tumor necrosis factor inhibitors Grant 8,765,810 - Greene , et al. July 1, 2 | 2014-07-01 |
| Sublingual buccal effervescent Grant 8,753,611 - Eichman , et al. June 17, 2 | 2014-06-17 |
| Bendamustine Pharmaceutical Compositions App 20140148490 - Brittain; Jason Edward ; et al. | 2014-05-29 |
| Pyridazinone Derivatives App 20140142088 - Bacon; Edward R. ; et al. | 2014-05-22 |
| Crystalline forms of a pharmaceutical compound Grant 8,729,065 - Rock , et al. May 20, 2 | 2014-05-20 |
| Sublingual buccal effervescent Grant 8,728,441 - Eichman , et al. May 20, 2 | 2014-05-20 |
| Liquid Formulations Of Bendamustine App 20140128443 - Drager; Anthony S. ; et al. | 2014-05-08 |
| Multicyclic compounds and the use thereof Grant 8,716,493 - Chatterjee , et al. May 6, 2 | 2014-05-06 |
| Proteasome Inhibitors And Processes For Their Preparation, Purification And Use App 20140121182 - Bakale; Roger P. ; et al. | 2014-05-01 |
| Azaquinazoline Inhibitors of Atypical Protein Kinase C App 20140113882 - Breslin; Henry J. ; et al. | 2014-04-24 |
| Pharmaceutical formulations of modafinil Grant 8,686,047 - Heacock , et al. April 1, 2 | 2014-04-01 |
| Proteasome Inhibitors And Methods Of Using The Same App 20140088042 - Bernardini; Raffaella ; et al. | 2014-03-27 |
| Liquid Formulations of Bendamustine App 20140080881 - Drager; Anthony S. ; et al. | 2014-03-20 |
| Methods of treating disorders mediated by histamine H.sub.3 receptors using pyridazinone derivatives Grant 8,673,916 - Bacon , et al. March 18, 2 | 2014-03-18 |
| Solid forms of bendamustine hydrochloride Grant 8,669,279 - Cooper , et al. March 11, 2 | 2014-03-11 |
| Substituted phenoxypropylcycloamine derivatives as histamine-3 (H.sub.3) receptor ligands Grant 8,648,067 - Bacon , et al. February 11, 2 | 2014-02-11 |
| Macrocyclic Compounds as ALK, FAK and JAK2 Inhibitors App 20140031351 - Breslin; Henry J. ; et al. | 2014-01-30 |
| Janus Kinase 2 (jak2) Inhibitor For The Treatment Of Lupus App 20140024655 - Dobrzanski; Pawel T. ; et al. | 2014-01-23 |
| Preparation and uses of 1,2,4-triazolo [1,5a] pyridine derivatives Grant 8,633,173 - Curry , et al. January 21, 2 | 2014-01-21 |
| Forms of a multicyclic compound Grant 8,633,314 - Bierlmaier , et al. January 21, 2 | 2014-01-21 |
| Substituted Aromatic Sulfur Compounds and Methods of Their Use App 20140005175 - Dorsey; Bruce D. ; et al. | 2014-01-02 |
| Proteasome Inhibitor Delanzomib For Use In The Treatment Of Lupus App 20130345174 - Ruggeri; Bruce A. ; et al. | 2013-12-26 |
| Bendamustine Pharmaceutical Compositions App 20130338205 - Brittain; Jason Edward ; et al. | 2013-12-19 |
| Bendamustine pharmaceutical compositions Grant 8,609,863 - Brittain , et al. December 17, 2 | 2013-12-17 |
| Methods For The Preparation Of Bendamustine App 20130310571 - Gayring; Anton H. ; et al. | 2013-11-21 |
| Substituted Spirocyclic Piperidine Derivatives As Histamine-3 (h3) Receptor Ligands App 20130310389 - Dandu; Reddeppa reddy ; et al. | 2013-11-21 |
| Aryl pyridazinone derivatives and their use as H3 receptor ligands Grant 8,586,588 - Bacon , et al. November 19, 2 | 2013-11-19 |
| Modafinil pharmaceutical compositions Grant 8,580,308 - Heacock , et al. November 12, 2 | 2013-11-12 |
| Preparation and Uses of 1,2,4-Triazolo [1,5a] Pyridine Derivatives App 20130296312 - Curry; Matthew A. ; et al. | 2013-11-07 |
| Treatment of Chronic Inflammation with a 1,2,4-Triazolo [1,5a] Pyridine Derivative App 20130267535 - Dobrzanski; Pawel T. ; et al. | 2013-10-10 |
| Fused bicyclic derivatives of 2,4-diaminopyrimidine as ALK and c-MET inhibitors Grant 8,552,186 - Ahmed , et al. October 8, 2 | 2013-10-08 |
| Proteasome inhibitors and methods of using the same Grant 8,546,608 - Bernardini , et al. October 1, 2 | 2013-10-01 |
| Proteasome inhibitors and processes for their preparation, purification and use Grant 8,541,590 - Roemmele September 24, 2 | 2013-09-24 |
| Novel Solid Forms Of Bendamustine Hydrochloride App 20130245086 - Cooper; Martin Ian ; et al. | 2013-09-19 |
| Substituted spirocyclic piperidine derivatives as histamine-3 (H.sub.3) receptor ligands Grant 8,524,713 - Dandu , et al. September 3, 2 | 2013-09-03 |
| Forms of a fused pyrrolocarbazole compound Grant 8,513,272 - Bierlmaier , et al. August 20, 2 | 2013-08-20 |
| Substituted spirocyclic piperidine derivatives as histamine-3 (H3) receptor ligands Grant 8,513,232 - Bacon , et al. August 20, 2 | 2013-08-20 |
| Preparation and uses of 1,2,4-triazolo [1,5a] pyridine derivatives Grant 8,501,936 - Curry , et al. August 6, 2 | 2013-08-06 |
| Pyrrolotriazines as ALK and JAK2 inhibitors Grant 8,471,005 - Breslin , et al. June 25, 2 | 2013-06-25 |
| Modafinil Formulations App 20130156825 - Bentolila; Moshe ; et al. | 2013-06-20 |
| Bendamustine pharmaceutical compositions Grant 8,461,350 - Brittain , et al. June 11, 2 | 2013-06-11 |
| Methods for the Sterilization of Bendamustine App 20130144068 - LaBell; Rachel Y. ; et al. | 2013-06-06 |
| Solid forms of bendamustine hydrochloride Grant 8,445,524 - Courvoisier , et al. May 21, 2 | 2013-05-21 |
| Method for Purifying a Fused Pyrrolocarbazole Derivative App 20130123499 - Allwein; Shawn P. ; et al. | 2013-05-16 |
| Bendamustine pharmaceutical compositions Grant 8,436,190 - Brittain , et al. May 7, 2 | 2013-05-07 |
| Modafinil Compositions App 20130096345 - Hickey; Magali Bourghol ; et al. | 2013-04-18 |
| Processes for the preparation of bendamustine Grant 8,420,829 - Chen , et al. April 16, 2 | 2013-04-16 |
| Tumor Necrosis Factor Inhibitors App 20130072562 - GREENE; MARK I. ; et al. | 2013-03-21 |
| Fused pyrrolocarbazoles Grant 8,383,813 - Becknell , et al. February 26, 2 | 2013-02-26 |
| Substituted bicyclic pyrimidines Grant 8,354,414 - Bacon , et al. January 15, 2 | 2013-01-15 |
| Liquid formulations of bendamustine Grant 8,344,006 - Drager , et al. January 1, 2 | 2013-01-01 |
| Modafinil compositions Grant 8,338,646 - Hickey , et al. December 25, 2 | 2012-12-25 |
| Pharmaceutical Formulations of Modafinil App 20120322880 - Heacock; Craig ; et al. | 2012-12-20 |
| Pharmaceutical Formulations of Modafinil App 20120316244 - Heacock; Craig ; et al. | 2012-12-13 |
| Tumor necrosis factor inhibitors Grant 8,318,699 - Greene , et al. November 27, 2 | 2012-11-27 |
| Tricyclic Derivatives and Their Pharmaceutical Use and Compositions App 20120295882 - Bacon; Edward R. ; et al. | 2012-11-22 |
| Bicyclic aromatic sulfinyl derivatives Grant 8,314,155 - Bacon , et al. November 20, 2 | 2012-11-20 |
| Tricyclic Derivatives and Their Pharmaceutical Use and Compositions App 20120277186 - Allwein; Shawn P. ; et al. | 2012-11-01 |
| Effervescent oral opiate dosage forms and methods of administering opiates Grant 8,298,577 - Moe October 30, 2 | 2012-10-30 |
| Proteasome inhibitors and processes for their preparation, purification and use App 20120270840 - Roemmele; Renee Caroline | 2012-10-25 |
| Proteasome inhibitors and methods of using the same Grant 8,283,367 - Bernardini , et al. October 9, 2 | 2012-10-09 |
| Pharmaceutical formulations of modafinil Grant 8,268,892 - Heacock , et al. September 18, 2 | 2012-09-18 |
| Novel forms of a multicyclic compound App 20120214998 - Bierlmaier; Stephen ; et al. | 2012-08-23 |
| Pyridizinone derivatives and the use thereof as H3 inhibitors Grant 8,247,414 - Bacon , et al. August 21, 2 | 2012-08-21 |
| Fused Bicyclic Derivatives of 2,4-Diaminopyrimidine as ALK and c-MET Inhibitors App 20120165519 - Ahmed; Gulzar ; et al. | 2012-06-28 |
| Pyridazinone derivatives Grant 8,207,168 - Becknell , et al. June 26, 2 | 2012-06-26 |
| Oral Formulations Of Bendamustine App 20120157505 - LaBell; Rachel Y. ; et al. | 2012-06-21 |
| Liquid Formulations Of Bendamustine App 20120129904 - Drager; Anthony S. ; et al. | 2012-05-24 |
| Modafinil modified release pharmaceutical compositions Grant 8,153,159 - Parikh , et al. April 10, 2 | 2012-04-10 |
| Tricyclic aromatic and bis-phenyl sulfinyl derivatives Grant 8,153,667 - Bacon , et al. April 10, 2 | 2012-04-10 |
| Surface-treated Modafinil Particles App 20120082726 - AHMED; Salah U. ; et al. | 2012-04-05 |
| Fused bicyclic derivatives of 2,4-diaminopyrimidine as ALK and c-Met inhibitors Grant 8,148,391 - Ahmed , et al. April 3, 2 | 2012-04-03 |
| Composition For Transmucosal Delivery Of Polypeptides App 20120076757 - Durfee; Steve L. ; et al. | 2012-03-29 |
| Combination Therapy for the Treatment of Multiple Myeloma App 20120071445 - Berenson; James R. | 2012-03-22 |
| Novel Solid Forms Of Bendamustine Hydrochloride App 20120071532 - Cooper; Martin Ian ; et al. | 2012-03-22 |
| Effervescent oral fentanyl dosage form and methods of administering fentanyl Grant 8,119,158 - Moe , et al. February 21, 2 | 2012-02-21 |
| Proteasome Inhibitors and Methods of Using the Same App 20120041196 - Bernardini; Raffaella ; et al. | 2012-02-16 |
| Pyrrolotriazines As Alk And Jak2 Inhibitors App 20120028919 - Breslin; Henry J. ; et al. | 2012-02-02 |
| Generally linear effervescent oral fentanyl dosage form and methods of administering Grant 8,092,832 - Moe , et al. January 10, 2 | 2012-01-10 |
| Novel Fused Pyrrolocarbazoles App 20120004253 - Becknell; Nadine C. ; et al. | 2012-01-05 |
| Substituted Pyridazine Derivatives App 20120004231 - Hudkins; Robert L. ; et al. | 2012-01-05 |
| Fused pyrrolocarbazoles Grant 8,084,472 - Hudkins , et al. December 27, 2 | 2011-12-27 |
| Pyridopyrazines and derivatives thereof as ALK and c-Met inhibitors Grant 8,080,561 - Dorsey , et al. December 20, 2 | 2011-12-20 |
| Substituted pyridazine derivatives Grant 8,076,331 - Hudkins , et al. December 13, 2 | 2011-12-13 |
| Forms of bendamustine free base Grant 8,076,366 - Courvoisier , et al. December 13, 2 | 2011-12-13 |
| Crystalline forms of a pharmaceutical compound Grant 8,076,320 - Rock , et al. December 13, 2 | 2011-12-13 |
| Thio-substituted arylmethanesulfinyl derivatives Grant 8,071,604 - Lesur , et al. December 6, 2 | 2011-12-06 |
| Pyridazinone Derivatives App 20110288075 - Bacon; Edward R. ; et al. | 2011-11-24 |
| Proteasome inhibitors and methods of using the same Grant 8,058,262 - Bernardini , et al. November 15, 2 | 2011-11-15 |
| Fused pyrrolocarbazoles Grant 8,044,064 - Becknell , et al. October 25, 2 | 2011-10-25 |
| Novel Forms of a Fused Pyrrolocarbazole Compound App 20110230508 - Bierlmaier; Stephen ; et al. | 2011-09-22 |
| Oral Transmucosal Nicotine Dosage Form App 20110206621 - Agarwal; Vikas ; et al. | 2011-08-25 |
| Modafinil Formulations App 20110206744 - Bentolila; Moshe ; et al. | 2011-08-25 |
| Transmucosal Treatment Methods in Patients With Mucositis App 20110195996 - Darwish; Mona ; et al. | 2011-08-11 |
| Processes for the Preparation of Bendamustine App 20110190509 - Chen; Jian ; et al. | 2011-08-04 |
| Liquid Formulations Of Bendamustine App 20110190363 - Drager; Anthony S. ; et al. | 2011-08-04 |
| Thio-substituted biarylmethanesulfinyl derivatives Grant 7,981,907 - Bacon , et al. July 19, 2 | 2011-07-19 |
| PYRIDOPYRAZINES AND DERIVATIVES THEREOF AS ALK AND c-MET INHIBITORS App 20110160204 - Dorsey; Bruce D. ; et al. | 2011-06-30 |
| Proteasome Inhibitors and Methods of Using the Same App 20110144033 - Bernardini; Raffaella ; et al. | 2011-06-16 |
| Crystalline Forms of a Pharmaceutical Compound App 20110124629 - Rock; Michael Harold ; et al. | 2011-05-26 |
| Substituted Pyridazinone Derivatives as Histamine-3 (H3) Receptor Ligands App 20110098269 - Becknell; Nadine C. ; et al. | 2011-04-28 |
| Pyridopyrazines and derivatives thereof as ALK and c-MET inhibitors Grant 7,919,502 - Dorsey , et al. April 5, 2 | 2011-04-05 |
| Proteasome inhibitors and methods of using the same Grant 7,915,236 - Bernardini , et al. March 29, 2 | 2011-03-29 |
| Substituted Spirocyclic Piperidine Derivatives as Histamine-3 (H3) Receptor Ligands App 20110071131 - Bacon; Edward R. ; et al. | 2011-03-24 |
| Novel Multicyclic Compounds And The Use Thereof App 20110059959 - Chatterjee; Sankar ; et al. | 2011-03-10 |
| Substituted Bicyclic Pyrimidines App 20110053920 - Bacon; Edward R. ; et al. | 2011-03-03 |
| Enhanced Transmucosal Composition And Dosage Form App 20110021583 - Holl; Richard J. ; et al. | 2011-01-27 |
| Substituted pyrazolo[3,4-d]pyrimidines Grant 7,851,468 - Bacon , et al. December 14, 2 | 2010-12-14 |
| Substituted pyridazine derivatives App 20100311752 - Hudkins; Robert L. ; et al. | 2010-12-09 |
| Preparation and Uses of 1,2,4-Triazolo [1,5a] Pyridine Derivatives App 20100311693 - Curry; Matthew A. ; et al. | 2010-12-09 |
| Substituted Spirocyclic Piperidine Derivatives as Histamine-3 (H3) Receptor Ligands App 20100298332 - Dandu; Reddeppa reddy ; et al. | 2010-11-25 |
| Pyridazinone Derivatives App 20100280007 - Bacon; Edward R. ; et al. | 2010-11-04 |
| Pyridazinone Derivatives App 20100273779 - Bacon; Edward R. ; et al. | 2010-10-28 |
| Particle-forming compositions containing fused pyrrolocarbazoles Grant 7,795,246 - Dickason , et al. September 14, 2 | 2010-09-14 |
| Methods for preventing/treating damage to sensory hair cells and cochlear neurons Grant 7,789,610 - Ylikoski , et al. September 7, 2 | 2010-09-07 |
| Modafinil Compositions App 20100210731 - Hickey; Magali Bourghol ; et al. | 2010-08-19 |
| Novel Forms of Bendamustine Free Base App 20100210701 - Courvoisier; Laurent D. ; et al. | 2010-08-19 |
| Compositions comprising modafinil compounds Grant 7,749,540 - Jacobs , et al. July 6, 2 | 2010-07-06 |
| Novel Fused Pyrrolocarbazoles App 20100152196 - Becknell; Nadine C. ; et al. | 2010-06-17 |
| Fused [d]pyridazin-7-ones Grant 7,732,447 - Becknell , et al. June 8, 2 | 2010-06-08 |
| Novel Pharmaceutical Formulations of Modafinil App 20100129444 - Corvari; Vincent ; et al. | 2010-05-27 |
| Processes For Preparing (r)-2-methylpyrrolidine And (s)-2-methylpyrrolidine And Tartrate Salts Thereof App 20100121055 - Christie; Michael ; et al. | 2010-05-13 |
| Composition For Transmucosal Delivery Of Polypeptides App 20100111902 - Durfee; Steve L. ; et al. | 2010-05-06 |
| Surface-treated Modafinil Particles App 20100112045 - AHMED; Salah U. ; et al. | 2010-05-06 |
| Modafinil compound and cyclodextrin mixtures Grant 7,704,975 - Jacobs , et al. April 27, 2 | 2010-04-27 |
| Fused pyrrolocarbazoles Grant 7,671,064 - Hudkins , et al. March 2, 2 | 2010-03-02 |
| PYRIDOPYRAZINES AND DERIVATIVES THEREOF AS ALK AND c-MET INHIBITORS App 20100048576 - Dorsey; Bruce D. ; et al. | 2010-02-25 |
| Modafinil Formulations App 20090317481 - Bentolila; Moshe ; et al. | 2009-12-24 |
| Proteasome Inhibitors And Methods Of Using The Same App 20090291918 - Bernardini; Raffaella ; et al. | 2009-11-26 |
| Novel Solid Forms Of Bendamustine Hydrochloride App 20090264488 - Cooper; Martin Ian ; et al. | 2009-10-22 |
| Pyridopyrazines and derivatives thereof as ALK and c-Met inhibitors Grant 7,601,716 - Dorsey , et al. October 13, 2 | 2009-10-13 |
| Novel crystalline forms of Lestaurtinib App 20090227650 - Bierlmaier; Stephen ; et al. | 2009-09-10 |
| FUSED BICYCLIC DERIVATIVES OF 2,4-DIAMINOPYRIMIDINE AS ALK AND c-MET INHIBITORS App 20090221555 - Ahmed; Gulzar ; et al. | 2009-09-03 |
| Oral Transmucosal Nicotine Dosage Form App 20090214442 - Agarwal; Vikas ; et al. | 2009-08-27 |
| Proteasome inhibitors and methods of using the same Grant 7,576,206 - Bernardini , et al. August 18, 2 | 2009-08-18 |
| Modafinil compositions Grant 7,566,805 - Hickey , et al. July 28, 2 | 2009-07-28 |
| Novel Fused Pyrrolocarbazoles App 20090186888 - Hudkins; Robert L. ; et al. | 2009-07-23 |
| Microemulsion containing indolocarbazole compound and dosage forms containing the same App 20090155352 - Drager; Anthony S. ; et al. | 2009-06-18 |
| Fused pyrrolocarbazoles Grant 7,514,440 - Hudkins , et al. April 7, 2 | 2009-04-07 |
| Proteasome inhibitors and methods of using the same App 20090075936 - Bernardini; Raffaella ; et al. | 2009-03-19 |
| Thio-Substituted Biarylmethanesulfinyl Derivatives App 20090062284 - Bacon; Edward R. ; et al. | 2009-03-05 |
| Bicyclic aromatic sulfinyl derivatives App 20090042907 - Bacon; Edward R. ; et al. | 2009-02-12 |
| Thio-substituted arylmethanesulfinyl derivatives App 20090018143 - Lesur; Brigitte ; et al. | 2009-01-15 |
| Modafinil compositions App 20090018202 - Hickey; Magali Bourghol ; et al. | 2009-01-15 |
| Proteasome inhibitors and methods of using the same Grant 7,468,383 - Bernardini , et al. December 23, 2 | 2008-12-23 |
| Transmucosal treatment methods in patients with mucositis App 20080287494 - Darwish; Mona ; et al. | 2008-11-20 |
| Thio-substituted biaryl-methanesulfinyl derivatives Grant 7,449,481 - Bacon , et al. November 11, 2 | 2008-11-11 |
| Substituted indole derivatives Grant 7,446,122 - Chao , et al. November 4, 2 | 2008-11-04 |
| Bicyclic aromatic sulfinyl derivatives Grant 7,423,176 - Bacon , et al. September 9, 2 | 2008-09-09 |
| Pharmaceutical formulations of modafinil App 20080207761 - Heacock; Craig S. ; et al. | 2008-08-28 |
| Modafinil pharmaceutical compositions App 20080181966 - Heacock; Craig ; et al. | 2008-07-31 |
| Method of radio-sensitizing tumors using a radio-sensitizing agent App 20080146556 - Diebold; James L. ; et al. | 2008-06-19 |
| Oral transmucosal nicotine dosage form App 20080131508 - Agarwal; Vikas ; et al. | 2008-06-05 |
| Separable solid dosage form administration system App 20080132830 - Hague; Brian ; et al. | 2008-06-05 |
| Tricyclic aromatic and bis-phenyl sulfinyl derivatives App 20080070956 - Bacon; Edward R. ; et al. | 2008-03-20 |
| Crystalline forms of tiagabine hydrochloride App 20080064727 - Childs; Scott L. ; et al. | 2008-03-13 |
| Novel pharmaceutical formulations of modafinil App 20080058424 - Corvari; Vincent ; et al. | 2008-03-06 |
| Crystalline and amorphous forms of tiagabine App 20080051435 - Childs; Scott L. ; et al. | 2008-02-28 |
| Pharmaceutical measuring and dispensing cup App 20080044314 - McIntyre; Bradley T. ; et al. | 2008-02-21 |
| Pyridopyrazines and derivatives thereof as alk and c-Met inhibitors App 20080032972 - Dorsey; Bruce D. ; et al. | 2008-02-07 |
| Substituted thioacetamides App 20080027228 - Bacon; Edward R. ; et al. | 2008-01-31 |
| Pyridizinone derivatives App 20080027041 - Hudkins; Robert L. ; et al. | 2008-01-31 |
| JAK inhibitors for treatment of myeloproliferative disorders App 20080021013 - Dobrzanski; Pawel ; et al. | 2008-01-24 |
| Tricyclic aromatic and bis-phenyl sulfinyl derivatives Grant 7,314,875 - Bacon , et al. January 1, 2 | 2008-01-01 |
| Tetrahydropyrano-indole derivatives Grant 7,314,886 - Chao , et al. January 1, 2 | 2008-01-01 |
| Fused [d]pyridazin-7-ones App 20070299061 - Becknell; Nadine C. ; et al. | 2007-12-27 |
| Dissolvable backing layer for use with a transmucosal delivery device Grant 7,306,812 - Zhang December 11, 2 | 2007-12-11 |
| Substituted pyrazolopyrimidines App 20070281949 - Bacon; Edward R. ; et al. | 2007-12-06 |
| Pharmaceutical formulations of modafinil Grant 7,297,346 - Corvari , et al. November 20, 2 | 2007-11-20 |
| Thio-substituted arylmethanesulfinyl derivatives Grant 7,297,817 - Lesur , et al. November 20, 2 | 2007-11-20 |
| Isomeric fused pyrrolocarbazoles and isoindolones Grant 7,291,732 - Hudkins November 6, 2 | 2007-11-06 |
| Cyclic substituted fused pyrrolocarbazoles and isoindolones Grant 7,288,650 - Hudkins , et al. October 30, 2 | 2007-10-30 |
| Dissolvable backing layer for use with a transmucosal delivery device Grant 7,276,246 - Zhang October 2, 2 | 2007-10-02 |
| Substituted thioacetamides Grant 7,268,132 - Bacon , et al. September 11, 2 | 2007-09-11 |
| Novel Fused Pyrrolocarbazoles App 20070203135 - Hudkins; Robert L. ; et al. | 2007-08-30 |
| Methods for detecting cell apoptosis Grant 7,256,252 - Siman , et al. August 14, 2 | 2007-08-14 |
| Portable container for disposing of a medicated oral dosage form Grant 7,243,799 - Hague July 17, 2 | 2007-07-17 |
| Fused pyrrolocarbazoles Grant 7,241,779 - Hudkins , et al. July 10, 2 | 2007-07-10 |
| Pharmaceutical formulations of modafinil Grant 7,229,644 - Corvari , et al. June 12, 2 | 2007-06-12 |
| Selected fused pyrrolocarbazoles Grant 7,230,026 - Gingrich , et al. June 12, 2 | 2007-06-12 |
| Proteasome inhibitors and methods of using the same Grant 7,223,745 - Chatterjee , et al. May 29, 2 | 2007-05-29 |
| Use of etodolac to treat hyperplasia Grant 7,211,599 - Carson , et al. May 1, 2 | 2007-05-01 |
| Substituted thioacetamides Grant RE39,575 - Bacon , et al. April 17, 2 | 2007-04-17 |
| Modafinil Pharmaceutical Compositions App 20070065517 - Heacock; Craig ; et al. | 2007-03-22 |
| Methods for purifying authentic IGF from yeast hosts Grant 7,193,042 - Cowgill , et al. March 20, 2 | 2007-03-20 |
| Fused pyrrolocarbazoles Grant 7,169,802 - Hudkins , et al. January 30, 2 | 2007-01-30 |
| Modafinil compositions App 20070021510 - Hickey; Magali Bourghol ; et al. | 2007-01-25 |
| Compositions and methods for the detection and treatment of methylthioadenosine phosphorylase deficient cancers Grant 7,157,551 - Leoni January 2, 2 | 2007-01-02 |
| Novel multicyclic compounds and the use thereof App 20060276497 - Chatterjee; Sankar ; et al. | 2006-12-07 |
| Modafinil compound and cyclodextrin mixtures Grant 7,141,555 - Jacobs , et al. November 28, 2 | 2006-11-28 |
| Novel fused pyrrolocarbazoles App 20060247294 - Becknell; Nadine C. ; et al. | 2006-11-02 |
| Multicyclic compounds and the use thereof Grant 7,122,679 - Ator , et al. October 17, 2 | 2006-10-17 |
| Selected fused pyrrolocarbazoles Grant 7,115,613 - Gingrich , et al. October 3, 2 | 2006-10-03 |
| Proteasome inhibitors and methods of using the same App 20060189806 - Bernardini; Raffaella ; et al. | 2006-08-24 |
| Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue Grant 7,087,647 - Miller , et al. August 8, 2 | 2006-08-08 |
| Direct racemization of indole derivatives App 20060167259 - Chao; Qi ; et al. | 2006-07-27 |
| Bendamustine pharmaceutical compositions App 20060159713 - Brittain; Jason Edward ; et al. | 2006-07-20 |
| Cyclic substituted fused pyrrolocarbazoles and isoindolones Grant 7,074,793 - Hudkins , et al. July 11, 2 | 2006-07-11 |
| Methods of purifying authentic IGF from yeast hosts Grant 7,071,313 - Cowgill , et al. July 4, 2 | 2006-07-04 |
| Selected fused pyrrolocarbazoles App 20060135590 - Gingrich; Diane E. ; et al. | 2006-06-22 |
| Cyclic substituted fused pyrrolocarbazoles and isoindolones App 20060128780 - Hudkins; Robert L. ; et al. | 2006-06-15 |
| Hydroxamate-containing cysteine and serine protease inhibitors Grant 7,060,683 - Josef , et al. June 13, 2 | 2006-06-13 |
| Preparations of a sulfinyl acetamide Grant 7,057,069 - Largeau , et al. June 6, 2 | 2006-06-06 |
| Peptide-containing alpha-ketoamide cysteine and serine protease inhibitors App 20060069037 - Chatterjee; Sankar ; et al. | 2006-03-30 |
| Methods for the treatment and prevention of pain Grant 7,018,999 - Aimone , et al. March 28, 2 | 2006-03-28 |
| Methods of treating proliferative skin diseases using carbazole derivatives App 20060058250 - Denmeade; Samuel R. ; et al. | 2006-03-16 |
| System for identification of a pharmaceutical product App 20060004035 - Barr; Charles M. ; et al. | 2006-01-05 |
| Thio-substituted biaryl-methanesulfinyl derivatives App 20050245747 - Bacon, Edward R. ; et al. | 2005-11-03 |
| Tricyclic aromatic and bis-phenyl sulfinyl derivatives App 20050234040 - Bacon, Edward R. ; et al. | 2005-10-20 |
| Bicyclic aromatic sulfinyl derivatives App 20050228040 - Bacon, Edward R. ; et al. | 2005-10-13 |
| Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation App 20050222257 - Rebiere, Francois ; et al. | 2005-10-06 |
| Substituted thioacetamides App 20050192313 - Bacon, Edward R. ; et al. | 2005-09-01 |
| Preparations of a sulfinyl acetamide App 20050171209 - Largeau, Denis ; et al. | 2005-08-04 |
| Substituted thioacetamides Grant 6,919,367 - Bacon , et al. July 19, 2 | 2005-07-19 |
| Pharmaceutical solutions of modafinil compounds Grant 6,919,378 - Jacobs , et al. July 19, 2 | 2005-07-19 |
| Isomeric fused pyrrolocarbazoles and isoindolones App 20050107458 - Hudkins, Robert L. | 2005-05-19 |
| Modafinil modified release pharmaceutical compositions App 20050095294 - Parikh, Alpa ; et al. | 2005-05-05 |
| Selected derivatives of K-252a Grant 6,875,865 - Hudkins , et al. April 5, 2 | 2005-04-05 |
| Preparations of a sulfinyl acetamide Grant 6,875,893 - Largeau , et al. April 5, 2 | 2005-04-05 |
| Isomeric fused pyrrolocarbazoles and isoindolones Grant 6,872,746 - Hudkins March 29, 2 | 2005-03-29 |
| Cyclic substituted fused pyrrolocarbazoles and isoindolones Grant 6,841,567 - Hudkins , et al. January 11, 2 | 2005-01-11 |
| Heterocyclic substituted pyrazolones Grant 6,831,075 - Singh , et al. December 14, 2 | 2004-12-14 |
| Analeptic and antidepressant combinations App 20040242698 - Hughes, Rodney J. | 2004-12-02 |
| Analeptic and antidepressant combinations App 20040229942 - Hassman, Howard A. ; et al. | 2004-11-18 |
| Analeptic and antidepressant combinations App 20040229940 - Hassman, Howard A. ; et al. | 2004-11-18 |
| Analeptic and drug combinations App 20040229943 - Hughes, Rodney J. ; et al. | 2004-11-18 |
| Analeptic and antidepressant combinations App 20040229941 - Hassman, Howard A. ; et al. | 2004-11-18 |
| Dissolvable backing layer for use with a transmucosal delivery device App 20040224007 - Zhang, Hao | 2004-11-11 |
| IGF-I purification process Grant 6,756,484 - Brierley , et al. June 29, 2 | 2004-06-29 |
| Gene-targeted non-human mammal with human fad presenilin mutation and generational offspring Grant 6,734,336 - Scott , et al. May 11, 2 | 2004-05-11 |
| Treating disorders by application of insulin-like growth factors and analogs Grant 6,723,699 - Lewis , et al. April 20, 2 | 2004-04-20 |
| Peptide-containing .alpha.-ketoamide cysteine and serine protease inhibitors Grant 6,703,368 - Chatterjee , et al. March 9, 2 | 2004-03-09 |
| Treating disorders by application of insulin-like growth factors and analogs Grant 6,693,076 - Lewis , et al. February 17, 2 | 2004-02-17 |
| Hydroxamate-containing cysteine and serine protease inhibitors Grant 6,686,335 - Josef , et al. February 3, 2 | 2004-02-03 |
| Substituted thioacetamides Grant 6,670,358 - Bacon , et al. December 30, 2 | 2003-12-30 |
| Particle-forming compositions containing fused pyrrolocarbazoles Grant 6,660,729 - Dickason , et al. December 9, 2 | 2003-12-09 |
| Selected soluble esters of hydroxyl-containing indolocarbazoles Grant RE38,332 - Mallamo , et al. November 25, 2 | 2003-11-25 |
| Isomeric fused pyrrolocarbazoles and isoindolones Grant 6,635,669 - Hudkins October 21, 2 | 2003-10-21 |
| Selected fused pyrrolocarbazoles Grant 6,630,500 - Gingrich , et al. October 7, 2 | 2003-10-07 |
| Method of treating cancer with anti-neurotrophin agents Grant 6,548,062 - Buchkovich , et al. April 15, 2 | 2003-04-15 |
Company Registrations
| NCAGE Code | 1NXE0 | CEPHALON INC. |
| CAGE Code | 1NXE0 | CEPHALON INC. |
| SEC | 0000873364 | CEPHALON INC of DELAWARE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 